Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy

Publikation: Bidrag til tidsskriftLetterForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{d11a4f2b851a4440bd6672ff226750ad,
title = "Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy",
keywords = "Aged, Antirheumatic Agents/administration & dosage, Bone Marrow Examination/methods, Dexamethasone/administration & dosage, Fatal Outcome, Humans, Immunoglobulins, Intravenous/administration & dosage, Infliximab/administration & dosage, Leishmaniasis, Visceral/diagnosis, Lymphohistiocytosis, Hemophagocytic/diagnosis, Male, Patient Care Management/methods, Sarcoidosis/drug therapy, Tumor Necrosis Factor-alpha/antagonists & inhibitors",
author = "Bukan, {K B} and A Nardo-Marino and C Hagdrup and M Boennelycke and Breinholdt, {M F} and C Sch{\"o}llkopf and Nielsen, {H V} and {El Fassi}, D",
year = "2019",
doi = "10.1080/03009742.2018.1533035",
language = "English",
volume = "48",
pages = "342--343",
journal = "Scandinavian Journal of Rheumatology",
issn = "0300-9742",
publisher = "Informa Healthcare",
number = "4",

}

RIS

TY - JOUR

T1 - Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation

T2 - a potential adverse event to anti-tumour necrosis factor-α therapy

AU - Bukan, K B

AU - Nardo-Marino, A

AU - Hagdrup, C

AU - Boennelycke, M

AU - Breinholdt, M F

AU - Schöllkopf, C

AU - Nielsen, H V

AU - El Fassi, D

PY - 2019

Y1 - 2019

KW - Aged

KW - Antirheumatic Agents/administration & dosage

KW - Bone Marrow Examination/methods

KW - Dexamethasone/administration & dosage

KW - Fatal Outcome

KW - Humans

KW - Immunoglobulins, Intravenous/administration & dosage

KW - Infliximab/administration & dosage

KW - Leishmaniasis, Visceral/diagnosis

KW - Lymphohistiocytosis, Hemophagocytic/diagnosis

KW - Male

KW - Patient Care Management/methods

KW - Sarcoidosis/drug therapy

KW - Tumor Necrosis Factor-alpha/antagonists & inhibitors

U2 - 10.1080/03009742.2018.1533035

DO - 10.1080/03009742.2018.1533035

M3 - Letter

VL - 48

SP - 342

EP - 343

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

SN - 0300-9742

IS - 4

ER -

ID: 56689966